Oppenheimer analyst Michael Wiederhorn is updating its Amedisys (AMED) model following the Q4 earnings release. Amedisys is currently in the ...

Among the blue-chip -laden Dow Jones Industrial Average ( ^DJI 1.65%), the two worst-performing stocks in the month of ...

In addition, the department has sued to block UnitedHealth's $3.3 billion of Amedisys Inc. (AMED), saying the deal would hinder home health and hospice services. UnitedHealth's Optum business is a ...

The investigation is the latest worry for UnitedHealth, which is already facing an antitrust probe and regulatory pushback over its planned $3.3 billion acquisition of Amedisys. UnitedHealth has ...

Shares of UnitedHealth Group closed down 7.3% to $465.69 on Friday. Amedisys (AMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report.

(2) Adjusted EBITDA is defined as net (loss) income attributable to Amedisys, Inc. before net interest expense, provision for income taxes and depreciation and amortization, excluding certain ...

Additionally, the department blocked UnitedHealth’s $3.3 billion acquisition of Amedisys, a home health company last year. UnitedHealth Group is the parent company of UnitedHealthcare ...

Also, UnitedHealth has clarified that the company ... although the DoJ has sued to block the deal with Amedisys, although a trial isn’t expected to take place until later this year or even ...

New Jersey and New York filed a civil antitrust lawsuit to block UnitedHealth Group's proposed $3.3 billion acquisition of rival home health and hospice services provider Amedisys Inc. over ...

The Department of Justice has reportedly launched an investigation into UnitedHealth Group’s Medicare billing practices as scrutiny over the health insurance industry intensifies — sending the ...